Key Takeaways TotalEnergies secured the 1 GW N-9.4 offshore wind concession in the North Sea for a 25-year term. TTE aims to cut costs by developing N-9.4 alongside nearby N-9.1 and N-9.2 sites with RWE. TTE will pay $20.7M to Germany for marine efforts and $9.3M annually to the grid operator for 20 years.TotalEnergies SE (TTE) announced that it has been awarded the N-9.4 offshore concession by the Federal Network Agency. TTE is a shareholder of North Sea OFW One GmbH. The primary benefit of offshore wind ...

Top national builder now selling at Newport Pointe in Discovery Bay and Malana at Lakeview in Mountain HouseSACRAMENTO, Calif., June 18, 2025 /PRNewswire/ -- Century Communities, Inc. (NYSE: CCS)—a top national homebuilder, industry leader in online home sales, and featured on America's Most Trustworthy Companies and World's Most Trustworthy Companies by Newsweek—announced that the company will host two Grand Opening celebrations on June 21 for Newport Pointe (now selling in Discovery Bay) and Malana at Lak ...

Key Takeaways WidePoint is positioned to benefit from rising federal IT spending and growing contract momentum. WYY gained FedRAMP authorization and is progressing under DoD's Spiral 4 and DHS' CWMS 3.0 efforts. With a recent stock drop, WYY trades at a low 0.18X P/S ratio, far below the 1.81X industry average.WidePoint Corporation (WYY) appears well-positioned to benefit from rising federal IT spending, particularly through its strategic alignment with key government priorities and growing contract momen ...

Applied Materials, Inc. (NASDAQ: AMAT ) shows a very common picture in 2025. Strong, profitable businesses with very rich valuations. Until the market decides to care, the stocks can stay elevated. And, dips will be bought. Based on the many market cyclesI'm Rob Isbitts, founder of Sungarden Investment Publishing. I run the new investing group Sungarden Investors Club, a community dedicated to navigating the modern investment climate with humility, discipline, and a non-traditional approach to income invest ...

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS ) is a biotechnology company with three commercial products generating sales and proprietary formulation modification technologies. I recommend that investors monitor this company as its revenue is accelerating thanks to the sales ofAnalyst’s Disclosure:I/we have a beneficial long position in the shares of XERS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensat ...

Key Takeaways Boston Scientific's Neuromodulation segment posted 6.8% operational sales growth in Q1 2025. BSX saw strong gains from Intracept, Cartesia leads, and Lumina 3D within pain and brain therapies. Boston Scientific expects continued growth in 2025, aided by Relievant and Axonics acquisitions.Boston Scientific’s (BSX) Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. This segment reflects the company’s long-term co ...

Key Takeaways XOM's upstream business benefits as oil prices near $75 amid rising Iran-Israel tensions. ExxonMobil revised expected synergies from its Pioneer deal up to $3B annually for the next decade. XOM's strong Permian presence and high crude prices are driving significant cash flow growth.The West Texas Intermediate crude price is currently nearing the $75-per-barrel benchmark, representing a significant improvement from $60.79 on May 30, thanks to the escalating tensions between Iran and Israel. T ...

Oscar Health, Inc. (OSCR) shares soared 7.8% in the last trading session to close at $16.11. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 14.7% loss over the past four weeks.The surge was likely driven by reports that lawmakers are proposing a measure allowing individuals and employers to voluntarily enroll in a revamped version of Medicare.Oscar noted about 12% of household income is spent on employer-sponsored health plans, ...

Key Takeaways UIS raised its 2025 L&S revenue outlook to $410M, up from $390M on stronger client demand. Higher AI adoption and longer renewals are driving deeper reliance on its platforms. With 65% of L&S revenues due in second half, UIS expects stronger cash flow stability through year-end.Unisys Corporation (UIS) is leaning more heavily on its Licensing and Support (L&S) services, which emerged as a bright spot in the first-quarter 2025 performance. The company expects L&S revenues in 2025 to hit $410 ...

A strong stock as of late has been Flex (FLEX) . Shares have been marching higher, with the stock up 7.1% over the past month. The stock hit a new 52-week high of $45.84 in the previous session. Flex has gained 17.9% since the start of the year compared to the 1.6% gain for the Zacks Computer and Technology sector and the -19.5% return for the Zacks Electronics - Miscellaneous Products industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed ...